Inclusion Body Myositis Overview
Learn About Inclusion Body Myositis
- Inclusion body myositis
- IBM
- Inflammatory myopathy
- Sporadic inclusion body myositis
Office
Richard Barohn is a Neurologist in Kansas City, Kansas. Dr. Barohn is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. His top areas of expertise are Inclusion Body Myositis, Myositis, Myasthenia Gravis, Thymectomy, and Tissue Biopsy.
Johns Hopkins Bayview Medical Center
Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis.
Johns Hopkins Bayview Medical Center
Andrew Mammen is a Neuromusculoskeletal Medicine specialist and a Neurologist in Baltimore, Maryland. Dr. Mammen is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. His top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Necrotizing Myopathy (NM).
Summary: Refer to the Detailed Description section.
Summary: To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


